Matthew Keller
Concepts (476)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 44 | 2025 | 1403 | 4.850 |
Why?
| | Polymorphism, Single Nucleotide | 54 | 2025 | 2134 | 4.590 |
Why?
| | Biological Specimen Banks | 7 | 2025 | 99 | 4.090 |
Why?
| | Multifactorial Inheritance | 17 | 2025 | 178 | 3.140 |
Why?
| | Models, Genetic | 23 | 2025 | 591 | 3.100 |
Why?
| | Schizophrenia | 16 | 2022 | 454 | 2.960 |
Why?
| | Genetic Predisposition to Disease | 35 | 2025 | 2363 | 2.860 |
Why?
| | Gene-Environment Interaction | 9 | 2021 | 187 | 1.910 |
Why?
| | Homozygote | 11 | 2023 | 201 | 1.800 |
Why?
| | Genome, Human | 13 | 2021 | 420 | 1.720 |
Why?
| | Genetics, Population | 5 | 2022 | 209 | 1.680 |
Why?
| | Depressive Disorder, Major | 7 | 2022 | 374 | 1.650 |
Why?
| | Phenotype | 32 | 2025 | 3166 | 1.640 |
Why?
| | Genetic Variation | 19 | 2022 | 1000 | 1.550 |
Why?
| | Paternal Inheritance | 2 | 2021 | 3 | 1.380 |
Why?
| | Maternal Inheritance | 2 | 2021 | 15 | 1.370 |
Why?
| | Statistics as Topic | 3 | 2021 | 302 | 1.350 |
Why?
| | Dermatology | 3 | 2025 | 122 | 1.310 |
Why?
| | Consanguinity | 4 | 2018 | 49 | 1.220 |
Why?
| | United Kingdom | 9 | 2025 | 322 | 1.150 |
Why?
| | Mental Disorders | 12 | 2022 | 1120 | 1.130 |
Why?
| | Quantitative Trait, Heritable | 8 | 2025 | 124 | 1.120 |
Why?
| | Family | 7 | 2024 | 680 | 1.110 |
Why?
| | Sequence Analysis, DNA | 3 | 2017 | 824 | 1.100 |
Why?
| | Twins | 5 | 2021 | 225 | 1.100 |
Why?
| | Twins, Dizygotic | 6 | 2013 | 163 | 1.070 |
Why?
| | Family Characteristics | 2 | 2025 | 192 | 1.040 |
Why?
| | Humans | 143 | 2025 | 141197 | 1.030 |
Why?
| | Marriage | 3 | 2025 | 123 | 1.010 |
Why?
| | Genome | 3 | 2018 | 302 | 1.010 |
Why?
| | Academic Success | 2 | 2023 | 31 | 0.990 |
Why?
| | Cognition | 15 | 2022 | 1222 | 0.970 |
Why?
| | Twins, Monozygotic | 5 | 2013 | 190 | 0.970 |
Why?
| | Reproduction | 4 | 2022 | 206 | 0.930 |
Why?
| | Software | 3 | 2017 | 676 | 0.910 |
Why?
| | Smoking | 7 | 2025 | 1601 | 0.900 |
Why?
| | Family Health | 2 | 2024 | 194 | 0.890 |
Why?
| | Infant, Low Birth Weight | 1 | 2025 | 146 | 0.880 |
Why?
| | Environment | 5 | 2017 | 341 | 0.860 |
Why?
| | Spouses | 1 | 2025 | 108 | 0.850 |
Why?
| | Sexual Partners | 1 | 2025 | 189 | 0.830 |
Why?
| | Linkage Disequilibrium | 6 | 2025 | 255 | 0.820 |
Why?
| | Depression | 4 | 2022 | 1483 | 0.820 |
Why?
| | Genotype | 13 | 2021 | 1859 | 0.810 |
Why?
| | Genetics, Behavioral | 2 | 2020 | 34 | 0.800 |
Why?
| | Body Height | 6 | 2025 | 196 | 0.790 |
Why?
| | Biological Evolution | 4 | 2018 | 490 | 0.760 |
Why?
| | Mentors | 2 | 2025 | 210 | 0.750 |
Why?
| | Intelligence | 6 | 2025 | 134 | 0.740 |
Why?
| | Tobacco Use Disorder | 3 | 2025 | 245 | 0.710 |
Why?
| | Pedigree | 5 | 2024 | 511 | 0.690 |
Why?
| | Haplotypes | 4 | 2018 | 496 | 0.680 |
Why?
| | Educational Status | 8 | 2024 | 463 | 0.680 |
Why?
| | Female | 74 | 2025 | 75522 | 0.670 |
Why?
| | Computer Simulation | 7 | 2022 | 1015 | 0.670 |
Why?
| | Inbreeding Depression | 2 | 2021 | 3 | 0.660 |
Why?
| | Male | 63 | 2025 | 69789 | 0.640 |
Why?
| | Algorithms | 3 | 2022 | 1763 | 0.640 |
Why?
| | Research Design | 6 | 2018 | 1143 | 0.620 |
Why?
| | Alleles | 10 | 2024 | 891 | 0.620 |
Why?
| | Twin Studies as Topic | 3 | 2018 | 19 | 0.620 |
Why?
| | Bias | 5 | 2022 | 229 | 0.600 |
Why?
| | Alcoholism | 6 | 2025 | 821 | 0.580 |
Why?
| | Cervical Length Measurement | 1 | 2018 | 4 | 0.580 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 662 | 0.580 |
Why?
| | Psychological Trauma | 1 | 2019 | 55 | 0.570 |
Why?
| | Adult | 47 | 2025 | 39181 | 0.560 |
Why?
| | Genomics | 9 | 2023 | 814 | 0.540 |
Why?
| | Tympanoplasty | 1 | 2017 | 8 | 0.540 |
Why?
| | Tympanic Membrane Perforation | 1 | 2017 | 17 | 0.540 |
Why?
| | Auditory Threshold | 1 | 2017 | 43 | 0.530 |
Why?
| | Beauty | 2 | 2013 | 20 | 0.520 |
Why?
| | Blast Injuries | 1 | 2017 | 58 | 0.510 |
Why?
| | Drug Eruptions | 1 | 2016 | 29 | 0.510 |
Why?
| | Third-Party Consent | 1 | 2016 | 20 | 0.500 |
Why?
| | Erlotinib Hydrochloride | 1 | 2016 | 69 | 0.500 |
Why?
| | Proxy | 1 | 2016 | 30 | 0.500 |
Why?
| | Psychotic Disorders | 2 | 2016 | 178 | 0.500 |
Why?
| | Adaptation, Physiological | 3 | 2018 | 560 | 0.490 |
Why?
| | Patient Acceptance of Health Care | 3 | 2021 | 878 | 0.470 |
Why?
| | Genetic Loci | 9 | 2022 | 277 | 0.470 |
Why?
| | Creativity | 1 | 2015 | 17 | 0.470 |
Why?
| | Internship and Residency | 2 | 2025 | 1235 | 0.460 |
Why?
| | Communication Barriers | 1 | 2016 | 116 | 0.460 |
Why?
| | Informed Consent | 1 | 2016 | 189 | 0.450 |
Why?
| | Nootropic Agents | 3 | 2021 | 29 | 0.450 |
Why?
| | Socioeconomic Factors | 2 | 2019 | 1306 | 0.440 |
Why?
| | Body Mass Index | 5 | 2024 | 2382 | 0.440 |
Why?
| | Likelihood Functions | 5 | 2022 | 147 | 0.430 |
Why?
| | Quantitative Trait Loci | 4 | 2024 | 366 | 0.420 |
Why?
| | Genealogy and Heraldry | 1 | 2013 | 5 | 0.410 |
Why?
| | Cocaine-Related Disorders | 1 | 2015 | 136 | 0.400 |
Why?
| | Genetic Pleiotropy | 1 | 2013 | 31 | 0.400 |
Why?
| | Bipolar Disorder | 2 | 2015 | 276 | 0.400 |
Why?
| | Telemedicine | 1 | 2022 | 891 | 0.400 |
Why?
| | Wearable Electronic Devices | 2 | 2025 | 55 | 0.400 |
Why?
| | Depressive Disorder | 2 | 2007 | 394 | 0.390 |
Why?
| | Dementia | 1 | 2016 | 263 | 0.390 |
Why?
| | Metabolic Networks and Pathways | 1 | 2014 | 184 | 0.390 |
Why?
| | Affect | 2 | 2005 | 314 | 0.380 |
Why?
| | Middle Aged | 31 | 2025 | 34438 | 0.380 |
Why?
| | Genes, Recessive | 1 | 2012 | 78 | 0.370 |
Why?
| | Marijuana Abuse | 1 | 2015 | 231 | 0.360 |
Why?
| | Inbreeding | 1 | 2011 | 20 | 0.360 |
Why?
| | Gene Frequency | 6 | 2022 | 494 | 0.360 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 313 | 0.350 |
Why?
| | Sex Characteristics | 2 | 2013 | 788 | 0.350 |
Why?
| | Risk Factors | 14 | 2025 | 10438 | 0.330 |
Why?
| | Social Environment | 4 | 2019 | 295 | 0.330 |
Why?
| | Adaptation, Psychological | 3 | 2022 | 677 | 0.330 |
Why?
| | Genetic Markers | 3 | 2020 | 343 | 0.330 |
Why?
| | Substance-Related Disorders | 5 | 2025 | 1100 | 0.330 |
Why?
| | Bariatric Surgery | 2 | 2024 | 218 | 0.320 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2021 | 102 | 0.320 |
Why?
| | Live Birth | 2 | 2020 | 68 | 0.320 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2009 | 28 | 0.310 |
Why?
| | Uniparental Disomy | 1 | 2009 | 9 | 0.310 |
Why?
| | Models, Statistical | 5 | 2018 | 671 | 0.310 |
Why?
| | Negative-Pressure Wound Therapy | 2 | 2020 | 29 | 0.310 |
Why?
| | Life Change Events | 2 | 2007 | 153 | 0.300 |
Why?
| | Fathers | 1 | 2009 | 51 | 0.300 |
Why?
| | Stillbirth | 2 | 2019 | 74 | 0.300 |
Why?
| | Personality | 2 | 2012 | 139 | 0.290 |
Why?
| | Dysphonia | 2 | 2018 | 15 | 0.290 |
Why?
| | Registries | 2 | 2015 | 2135 | 0.290 |
Why?
| | Models, Theoretical | 3 | 2021 | 585 | 0.290 |
Why?
| | Aged | 16 | 2025 | 24576 | 0.290 |
Why?
| | Psychiatry | 1 | 2011 | 188 | 0.290 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 4 | 2025 | 239 | 0.290 |
Why?
| | Laryngeal Diseases | 2 | 2018 | 30 | 0.280 |
Why?
| | Evolution, Molecular | 2 | 2017 | 510 | 0.280 |
Why?
| | Mendelian Randomization Analysis | 3 | 2024 | 51 | 0.280 |
Why?
| | Psoriasis | 2 | 2021 | 110 | 0.280 |
Why?
| | Young Adult | 18 | 2025 | 13673 | 0.280 |
Why?
| | Parkinson Disease | 2 | 2025 | 569 | 0.280 |
Why?
| | Genetic Association Studies | 4 | 2019 | 372 | 0.280 |
Why?
| | Inheritance Patterns | 4 | 2021 | 44 | 0.280 |
Why?
| | Parent-Child Relations | 2 | 2021 | 285 | 0.270 |
Why?
| | Adolescent | 26 | 2025 | 22007 | 0.270 |
Why?
| | Myeloproliferative Disorders | 2 | 2019 | 27 | 0.270 |
Why?
| | Chromosomes, Human | 3 | 2018 | 44 | 0.270 |
Why?
| | Retrospective Studies | 16 | 2022 | 16273 | 0.260 |
Why?
| | Computational Biology | 1 | 2011 | 661 | 0.250 |
Why?
| | Pediatric Obesity | 2 | 2024 | 600 | 0.250 |
Why?
| | Chromosome Mapping | 3 | 2015 | 504 | 0.250 |
Why?
| | Reproducibility of Results | 4 | 2019 | 3348 | 0.240 |
Why?
| | Neurodevelopmental Disorders | 2 | 2019 | 196 | 0.240 |
Why?
| | Pregnancy | 7 | 2025 | 7070 | 0.240 |
Why?
| | Selection, Genetic | 2 | 2012 | 264 | 0.230 |
Why?
| | Weather | 1 | 2005 | 40 | 0.230 |
Why?
| | Surveys and Questionnaires | 6 | 2025 | 5929 | 0.230 |
Why?
| | Antineoplastic Agents | 1 | 2016 | 2166 | 0.230 |
Why?
| | Tobacco Products | 2 | 2024 | 129 | 0.220 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 2025 | 57 | 0.220 |
Why?
| | Biofeedback, Psychology | 1 | 2025 | 36 | 0.220 |
Why?
| | Executive Function | 2 | 2022 | 457 | 0.220 |
Why?
| | Pregnancy Complications | 2 | 2019 | 587 | 0.210 |
Why?
| | Apolipoproteins E | 1 | 2024 | 91 | 0.210 |
Why?
| | Alcohol Drinking | 2 | 2022 | 834 | 0.210 |
Why?
| | Recombination, Genetic | 2 | 2016 | 206 | 0.210 |
Why?
| | Cognition Disorders | 2 | 2019 | 515 | 0.200 |
Why?
| | Deglutition Disorders | 1 | 2025 | 148 | 0.200 |
Why?
| | Ureteral Calculi | 1 | 2022 | 12 | 0.200 |
Why?
| | Hidradenitis Suppurativa | 1 | 2022 | 11 | 0.190 |
Why?
| | Parents | 2 | 2022 | 1434 | 0.190 |
Why?
| | Lithotripsy | 1 | 2022 | 46 | 0.190 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2022 | 39 | 0.190 |
Why?
| | Population Health | 1 | 2023 | 48 | 0.190 |
Why?
| | Birth Weight | 1 | 2025 | 515 | 0.190 |
Why?
| | Face | 2 | 2013 | 175 | 0.190 |
Why?
| | Tobacco Use | 1 | 2022 | 65 | 0.190 |
Why?
| | Faculty, Medical | 1 | 2025 | 295 | 0.180 |
Why?
| | Receptors, Nicotinic | 2 | 2025 | 344 | 0.180 |
Why?
| | Internationality | 1 | 2022 | 158 | 0.180 |
Why?
| | Compartment Syndromes | 1 | 2022 | 30 | 0.180 |
Why?
| | Fractures, Open | 1 | 2022 | 32 | 0.180 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2022 | 434 | 0.180 |
Why?
| | Health Care Costs | 2 | 2022 | 424 | 0.180 |
Why?
| | Mutation, Missense | 2 | 2019 | 339 | 0.180 |
Why?
| | Arthritis, Psoriatic | 1 | 2021 | 21 | 0.180 |
Why?
| | Tibial Fractures | 1 | 2022 | 69 | 0.180 |
Why?
| | Respiratory Rate | 1 | 2021 | 21 | 0.180 |
Why?
| | Wireless Technology | 1 | 2021 | 17 | 0.180 |
Why?
| | Gastric Bypass | 1 | 2022 | 119 | 0.170 |
Why?
| | Genotyping Techniques | 2 | 2018 | 73 | 0.170 |
Why?
| | Tremor | 2 | 2018 | 97 | 0.170 |
Why?
| | Artificial Intelligence | 1 | 2025 | 334 | 0.170 |
Why?
| | Pregnancy, Twin | 1 | 2020 | 19 | 0.170 |
Why?
| | Respiratory Sounds | 1 | 2021 | 109 | 0.170 |
Why?
| | Inpatients | 2 | 2022 | 507 | 0.170 |
Why?
| | Arthroplasty, Replacement | 1 | 2021 | 46 | 0.170 |
Why?
| | Hospitalization | 5 | 2021 | 2255 | 0.160 |
Why?
| | Hysterectomy | 1 | 2021 | 138 | 0.160 |
Why?
| | Mental Health | 2 | 2024 | 749 | 0.160 |
Why?
| | Medicaid | 2 | 2021 | 451 | 0.150 |
Why?
| | Behavior, Addictive | 1 | 2020 | 89 | 0.150 |
Why?
| | Maternal Health | 1 | 2019 | 52 | 0.150 |
Why?
| | Duffy Blood-Group System | 1 | 2019 | 5 | 0.150 |
Why?
| | Florida | 4 | 2019 | 115 | 0.150 |
Why?
| | Friends | 1 | 2019 | 55 | 0.150 |
Why?
| | Exotoxins | 1 | 2019 | 16 | 0.150 |
Why?
| | History, 21st Century | 1 | 2020 | 220 | 0.150 |
Why?
| | Janus Kinase 2 | 1 | 2019 | 32 | 0.150 |
Why?
| | Orbital Cellulitis | 1 | 2019 | 17 | 0.150 |
Why?
| | Cone Opsins | 1 | 2018 | 2 | 0.150 |
Why?
| | Siblings | 2 | 2013 | 216 | 0.150 |
Why?
| | Minisatellite Repeats | 1 | 2019 | 40 | 0.150 |
Why?
| | Hemolysin Proteins | 1 | 2019 | 35 | 0.150 |
Why?
| | Dermatitis, Atopic | 1 | 2022 | 331 | 0.150 |
Why?
| | Laryngismus | 1 | 2018 | 11 | 0.150 |
Why?
| | History, 20th Century | 1 | 2020 | 329 | 0.150 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2018 | 21 | 0.150 |
Why?
| | Antimicrobial Stewardship | 1 | 2021 | 119 | 0.150 |
Why?
| | Obesity, Morbid | 1 | 2022 | 273 | 0.150 |
Why?
| | Chronic Pain | 1 | 2023 | 280 | 0.140 |
Why?
| | Urinary Tract Infections | 1 | 2021 | 194 | 0.140 |
Why?
| | Bacterial Toxins | 1 | 2019 | 104 | 0.140 |
Why?
| | Time-to-Treatment | 1 | 2020 | 217 | 0.140 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2019 | 84 | 0.140 |
Why?
| | Recurrence | 2 | 2019 | 1110 | 0.140 |
Why?
| | Lasers | 1 | 2018 | 130 | 0.140 |
Why?
| | Pregnancy Trimester, Second | 1 | 2018 | 83 | 0.140 |
Why?
| | Laparoscopy | 1 | 2022 | 463 | 0.140 |
Why?
| | Europe | 2 | 2022 | 410 | 0.140 |
Why?
| | Follow-Up Studies | 4 | 2025 | 5200 | 0.140 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2892 | 0.140 |
Why?
| | Needs Assessment | 1 | 2020 | 382 | 0.140 |
Why?
| | Cohort Studies | 6 | 2022 | 5799 | 0.140 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2020 | 186 | 0.140 |
Why?
| | Audiometry, Pure-Tone | 1 | 2017 | 30 | 0.130 |
Why?
| | Neuromuscular Agents | 1 | 2018 | 41 | 0.130 |
Why?
| | Pneumonia, Viral | 1 | 2022 | 374 | 0.130 |
Why?
| | Botulinum Toxins, Type A | 1 | 2018 | 52 | 0.130 |
Why?
| | Education, Medical, Graduate | 1 | 2022 | 522 | 0.130 |
Why?
| | Heart Rate | 1 | 2021 | 821 | 0.130 |
Why?
| | Mouth | 1 | 2017 | 88 | 0.130 |
Why?
| | Databases, Factual | 4 | 2025 | 1444 | 0.130 |
Why?
| | Event-Related Potentials, P300 | 1 | 2016 | 15 | 0.130 |
Why?
| | Synaptic Transmission | 1 | 2019 | 295 | 0.130 |
Why?
| | Neurocognitive Disorders | 1 | 2017 | 30 | 0.130 |
Why?
| | Endophenotypes | 1 | 2016 | 21 | 0.130 |
Why?
| | Hematologic Neoplasms | 1 | 2019 | 159 | 0.130 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 325 | 0.130 |
Why?
| | Parenting | 1 | 2020 | 319 | 0.130 |
Why?
| | Case-Control Studies | 4 | 2017 | 3588 | 0.130 |
Why?
| | Patient Discharge | 2 | 2022 | 932 | 0.130 |
Why?
| | Patient Readmission | 1 | 2022 | 706 | 0.130 |
Why?
| | Receptors, Cell Surface | 1 | 2019 | 397 | 0.130 |
Why?
| | Postpartum Period | 1 | 2019 | 353 | 0.130 |
Why?
| | Referral and Consultation | 1 | 2022 | 798 | 0.130 |
Why?
| | Phylogeny | 1 | 2021 | 1018 | 0.120 |
Why?
| | Influenza, Human | 1 | 2022 | 626 | 0.120 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 140 | 0.120 |
Why?
| | Retina | 1 | 2018 | 314 | 0.120 |
Why?
| | Regression Analysis | 3 | 2021 | 1020 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 627 | 0.120 |
Why?
| | DNA Copy Number Variations | 1 | 2016 | 176 | 0.120 |
Why?
| | Neoplasm Proteins | 1 | 2019 | 433 | 0.120 |
Why?
| | Telephone | 1 | 2016 | 182 | 0.120 |
Why?
| | Ambulatory Care | 1 | 2020 | 582 | 0.120 |
Why?
| | Pityriasis Rubra Pilaris | 1 | 2015 | 1 | 0.120 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2020 | 371 | 0.110 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2015 | 22 | 0.110 |
Why?
| | Curriculum | 1 | 2022 | 1033 | 0.110 |
Why?
| | Guanylate Cyclase | 1 | 2015 | 38 | 0.110 |
Why?
| | Aged, 80 and over | 5 | 2019 | 7856 | 0.110 |
Why?
| | Genetic Research | 1 | 2015 | 17 | 0.110 |
Why?
| | Staphylococcus aureus | 1 | 2019 | 437 | 0.110 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2015 | 125 | 0.110 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 1973 | 0.110 |
Why?
| | Comprehension | 1 | 2016 | 182 | 0.110 |
Why?
| | United States | 7 | 2025 | 15220 | 0.110 |
Why?
| | Staphylococcal Infections | 1 | 2019 | 392 | 0.110 |
Why?
| | Principal Component Analysis | 1 | 2015 | 194 | 0.110 |
Why?
| | Adolescent Behavior | 1 | 2019 | 538 | 0.110 |
Why?
| | Masculinity | 1 | 2013 | 9 | 0.110 |
Why?
| | Comorbidity | 2 | 2019 | 1662 | 0.110 |
Why?
| | Membrane Proteins | 2 | 2024 | 1155 | 0.110 |
Why?
| | Genetic Testing | 1 | 2017 | 460 | 0.100 |
Why?
| | Genetic Fitness | 1 | 2014 | 57 | 0.100 |
Why?
| | Antisocial Personality Disorder | 1 | 2015 | 153 | 0.100 |
Why?
| | Infant, Newborn | 1 | 2025 | 6275 | 0.100 |
Why?
| | Stress, Psychological | 1 | 2022 | 1128 | 0.100 |
Why?
| | Impulsive Behavior | 1 | 2015 | 154 | 0.100 |
Why?
| | Africa | 1 | 2013 | 119 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2015 | 325 | 0.100 |
Why?
| | Endothelial Cells | 1 | 2019 | 816 | 0.100 |
Why?
| | Interpersonal Relations | 2 | 2008 | 411 | 0.100 |
Why?
| | Biopsy | 1 | 2016 | 1081 | 0.100 |
Why?
| | Outpatients | 1 | 2016 | 420 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 914 | 0.100 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2250 | 0.100 |
Why?
| | Adolescent Development | 1 | 2013 | 90 | 0.100 |
Why?
| | Bacterial Proteins | 1 | 2019 | 911 | 0.090 |
Why?
| | Anxiety Disorders | 1 | 2016 | 379 | 0.090 |
Why?
| | Treatment Outcome | 4 | 2022 | 11120 | 0.090 |
Why?
| | Hematopoietic Stem Cells | 1 | 2015 | 411 | 0.090 |
Why?
| | Choice Behavior | 1 | 2013 | 172 | 0.090 |
Why?
| | Physician-Patient Relations | 1 | 2016 | 583 | 0.090 |
Why?
| | Parathyroid Glands | 1 | 2011 | 11 | 0.090 |
Why?
| | Homeostasis | 1 | 2015 | 636 | 0.090 |
Why?
| | Cell Cycle Proteins | 1 | 2015 | 624 | 0.090 |
Why?
| | Virginia | 2 | 2009 | 64 | 0.090 |
Why?
| | Life Style | 2 | 2021 | 482 | 0.090 |
Why?
| | Population Density | 1 | 2011 | 97 | 0.090 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2011 | 66 | 0.090 |
Why?
| | NF-kappa B | 1 | 2015 | 692 | 0.090 |
Why?
| | Child | 9 | 2024 | 22310 | 0.080 |
Why?
| | Spectrometry, Fluorescence | 1 | 2011 | 167 | 0.080 |
Why?
| | Military Personnel | 1 | 2017 | 613 | 0.080 |
Why?
| | Anthropometry | 2 | 2024 | 208 | 0.080 |
Why?
| | Microbiota | 1 | 2017 | 767 | 0.080 |
Why?
| | Sexual Behavior | 1 | 2013 | 497 | 0.080 |
Why?
| | Decision Making | 1 | 2016 | 961 | 0.070 |
Why?
| | International Classification of Diseases | 2 | 2019 | 138 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2902 | 0.070 |
Why?
| | Risk | 3 | 2019 | 904 | 0.070 |
Why?
| | Child Development | 1 | 2013 | 498 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2016 | 857 | 0.070 |
Why?
| | Prevalence | 1 | 2015 | 2772 | 0.070 |
Why?
| | Databases, Genetic | 1 | 2009 | 242 | 0.070 |
Why?
| | Thinking | 1 | 2008 | 69 | 0.070 |
Why?
| | Personality Inventory | 1 | 2007 | 144 | 0.070 |
Why?
| | Health Status | 2 | 2024 | 823 | 0.060 |
Why?
| | Incidence | 2 | 2025 | 2794 | 0.060 |
Why?
| | Analysis of Variance | 3 | 2018 | 1320 | 0.060 |
Why?
| | Diseases in Twins | 1 | 2007 | 159 | 0.060 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2011 | 772 | 0.060 |
Why?
| | Arthritis, Rheumatoid | 1 | 2015 | 1176 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2019 | 1261 | 0.060 |
Why?
| | Gestational Age | 2 | 2019 | 957 | 0.060 |
Why?
| | Length of Stay | 2 | 2022 | 1254 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2006 | 67 | 0.060 |
Why?
| | Personality Assessment | 1 | 2005 | 87 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2599 | 0.060 |
Why?
| | Transcriptome | 2 | 2022 | 1003 | 0.060 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2007 | 561 | 0.060 |
Why?
| | Ectodermal Dysplasia | 1 | 2005 | 18 | 0.060 |
Why?
| | Norway | 1 | 2024 | 45 | 0.060 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 2172 | 0.060 |
Why?
| | Connexin 43 | 1 | 2005 | 35 | 0.060 |
Why?
| | Social Isolation | 1 | 2005 | 66 | 0.060 |
Why?
| | Connexins | 1 | 2005 | 52 | 0.050 |
Why?
| | Australia | 1 | 2005 | 310 | 0.050 |
Why?
| | Mastectomy | 1 | 2025 | 153 | 0.050 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2024 | 16 | 0.050 |
Why?
| | Ureteroscopy | 1 | 2022 | 13 | 0.050 |
Why?
| | Mammaplasty | 1 | 2025 | 119 | 0.050 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2005 | 278 | 0.050 |
Why?
| | Child, Preschool | 4 | 2020 | 11457 | 0.050 |
Why?
| | Sample Size | 1 | 2022 | 128 | 0.050 |
Why?
| | Pruritus | 1 | 2022 | 64 | 0.050 |
Why?
| | Social Behavior | 2 | 2019 | 293 | 0.050 |
Why?
| | Paralysis | 1 | 2022 | 70 | 0.050 |
Why?
| | Lumbar Vertebrae | 1 | 2024 | 250 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 2025 | 601 | 0.040 |
Why?
| | Upper Extremity | 1 | 2022 | 107 | 0.040 |
Why?
| | Hand | 1 | 2022 | 163 | 0.040 |
Why?
| | Infant | 3 | 2020 | 9818 | 0.040 |
Why?
| | Brain | 3 | 2023 | 2858 | 0.040 |
Why?
| | Gene Expression | 1 | 2006 | 1491 | 0.040 |
Why?
| | Tibia | 1 | 2022 | 183 | 0.040 |
Why?
| | Students, Medical | 1 | 2025 | 364 | 0.040 |
Why?
| | Inappropriate Prescribing | 1 | 2021 | 58 | 0.040 |
Why?
| | Animals | 6 | 2019 | 37663 | 0.040 |
Why?
| | Bone Density | 1 | 2024 | 494 | 0.040 |
Why?
| | Mutation | 1 | 2011 | 4013 | 0.040 |
Why?
| | Social Sciences | 1 | 2019 | 8 | 0.040 |
Why?
| | Body Weight | 1 | 2024 | 996 | 0.040 |
Why?
| | Nebraska | 1 | 2019 | 19 | 0.040 |
Why?
| | Arkansas | 1 | 2019 | 20 | 0.040 |
Why?
| | Iowa | 1 | 2019 | 31 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2011 | 2087 | 0.040 |
Why?
| | Receptors, Thrombopoietin | 1 | 2019 | 7 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1820 | 0.040 |
Why?
| | Maryland | 1 | 2019 | 62 | 0.040 |
Why?
| | Wisconsin | 1 | 2019 | 101 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2019 | 29 | 0.040 |
Why?
| | Monitoring, Physiologic | 1 | 2021 | 285 | 0.040 |
Why?
| | New York | 1 | 2019 | 127 | 0.040 |
Why?
| | Ophthalmoscopy | 1 | 2018 | 38 | 0.040 |
Why?
| | Infrared Rays | 1 | 2018 | 26 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2019 | 93 | 0.040 |
Why?
| | Macaca fascicularis | 1 | 2018 | 69 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2019 | 44 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 532 | 0.040 |
Why?
| | Biometry | 1 | 2018 | 70 | 0.040 |
Why?
| | Morbidity | 1 | 2019 | 322 | 0.040 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2018 | 69 | 0.040 |
Why?
| | Laryngeal Muscles | 1 | 2018 | 12 | 0.040 |
Why?
| | Voice Quality | 1 | 2018 | 22 | 0.040 |
Why?
| | Cefotaxime | 1 | 2017 | 2 | 0.040 |
Why?
| | Counseling | 1 | 2021 | 398 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2019 | 310 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2024 | 583 | 0.030 |
Why?
| | Age Distribution | 1 | 2018 | 395 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 2018 | 131 | 0.030 |
Why?
| | Sex Distribution | 1 | 2018 | 379 | 0.030 |
Why?
| | Peer Group | 1 | 2019 | 247 | 0.030 |
Why?
| | Hospitals | 1 | 2022 | 696 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2018 | 521 | 0.030 |
Why?
| | Acute Disease | 1 | 2020 | 1008 | 0.030 |
Why?
| | Contactins | 1 | 2016 | 2 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 789 | 0.030 |
Why?
| | Odds Ratio | 1 | 2019 | 1052 | 0.030 |
Why?
| | Saccades | 1 | 2016 | 42 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 457 | 0.030 |
Why?
| | Linear Models | 2 | 2012 | 857 | 0.030 |
Why?
| | Reaction Time | 1 | 2018 | 429 | 0.030 |
Why?
| | Mice | 3 | 2019 | 18055 | 0.030 |
Why?
| | Mothers | 1 | 2022 | 785 | 0.030 |
Why?
| | Alcohol Abstinence | 1 | 2015 | 13 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 5636 | 0.030 |
Why?
| | Survival Analysis | 1 | 2019 | 1319 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 361 | 0.030 |
Why?
| | Cell Survival | 1 | 2019 | 1129 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2016 | 196 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1444 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1490 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2015 | 296 | 0.030 |
Why?
| | Finland | 1 | 2014 | 80 | 0.030 |
Why?
| | Logistic Models | 1 | 2019 | 2086 | 0.030 |
Why?
| | Rare Diseases | 1 | 2015 | 111 | 0.030 |
Why?
| | Genetic Phenomena | 1 | 2013 | 8 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1116 | 0.030 |
Why?
| | Synapses | 1 | 2017 | 428 | 0.030 |
Why?
| | Electroencephalography | 1 | 2016 | 523 | 0.030 |
Why?
| | Genetic Heterogeneity | 1 | 2013 | 58 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 2059 | 0.020 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2013 | 62 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2015 | 378 | 0.020 |
Why?
| | Conduct Disorder | 1 | 2015 | 187 | 0.020 |
Why?
| | Risk-Taking | 1 | 2015 | 345 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 95 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2021 | 1336 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 3068 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3292 | 0.020 |
Why?
| | Parathyroidectomy | 1 | 2011 | 9 | 0.020 |
Why?
| | Chromatin | 1 | 2015 | 529 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1828 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2011 | 35 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2019 | 4208 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3470 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4073 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3490 | 0.020 |
Why?
| | Thyroidectomy | 1 | 2011 | 97 | 0.020 |
Why?
| | Pediatrics | 1 | 2018 | 1094 | 0.020 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 78 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2021 | 1865 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4610 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2022 | 2797 | 0.020 |
Why?
| | Central Nervous System | 1 | 2012 | 265 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4175 | 0.020 |
Why?
| | Crohn Disease | 1 | 2013 | 254 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 6956 | 0.020 |
Why?
| | Trachea | 1 | 2011 | 255 | 0.020 |
Why?
| | Lung | 1 | 2022 | 4134 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2013 | 1085 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2014 | 1052 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4405 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2015 | 2003 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2011 | 647 | 0.020 |
Why?
| | Connexin 26 | 1 | 2005 | 8 | 0.010 |
Why?
| | Roma | 1 | 2005 | 2 | 0.010 |
Why?
| | Least-Squares Analysis | 1 | 2005 | 78 | 0.010 |
Why?
| | False Positive Reactions | 1 | 2005 | 125 | 0.010 |
Why?
| | Motor Cortex | 1 | 2005 | 62 | 0.010 |
Why?
| | Data Collection | 1 | 2008 | 661 | 0.010 |
Why?
| | Interviews as Topic | 1 | 2008 | 844 | 0.010 |
Why?
| | Functional Laterality | 1 | 2005 | 240 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2005 | 398 | 0.010 |
Why?
| | Psychomotor Performance | 1 | 2005 | 329 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1056 | 0.010 |
Why?
| | Signal Transduction | 1 | 2015 | 5144 | 0.010 |
Why?
| | Pain | 1 | 2005 | 781 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2005 | 3709 | 0.010 |
Why?
|
|
Keller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|